These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 582412)

  • 1. [The toxicity of lincomycin. Two i.v. applications of 6 g. each to a 10 year old girl without toxic symptoms].
    Widhalm K; Salzman G
    Arzneimittelforschung; 1978; 28(8):1428-30. PubMed ID: 582412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimal regime of intravenous administration of lincomycin in osteomyelitis].
    Koroleva VG; Fishman VM; Firsov AA
    Antibiotiki; 1977 Apr; 22(4):335-40. PubMed ID: 883786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to parenteral lincomycin.
    Berry DD; Brouhard BH; Box QT
    Pediatrics; 1981 Mar; 67(3):389-91. PubMed ID: 7017577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
    Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
    Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lincomycin therapy of osteomyelitis].
    Edeling CJ
    Ugeskr Laeger; 1968 Dec; 130(52):2271-5. PubMed ID: 5716699
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience in the use of lincomycin in the treatment of staphylococcal infections in traumatologic and orthopedic patients].
    Mel'nikova VM; Gladshteĭn AI; Gudushauri ON; Markova ON
    Antibiotiki; 1969 Sep; 14(9):858-61. PubMed ID: 5196670
    [No Abstract]   [Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution to the rational treatment of staphylococcal osteomyelitis with lincomycin].
    Vacek V; Hejzlar M; Pavlanský R
    Cas Lek Cesk; 1968 Dec; 107(50):1505-14. PubMed ID: 5711202
    [No Abstract]   [Full Text] [Related]  

  • 14. Contribution to the therapy with high doses of lincomycin.
    Vacek V; Hejzlar M
    Arzneimittelforschung; 1968 Nov; 18(11):1457-8. PubMed ID: 5755912
    [No Abstract]   [Full Text] [Related]  

  • 15. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the use of 7-chlor-7-desoxylincomycin in pediatrics].
    Daschner F; Marget W
    Arzneimittelforschung; 1969 Jun; 19(6):1003-6. PubMed ID: 5820027
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with lincomycin from the clinic and laboratory].
    Vacek V; Hejzlar M
    Arzneimittelforschung; 1966 Dec; 16(12):1600-6. PubMed ID: 4385186
    [No Abstract]   [Full Text] [Related]  

  • 18. [Microbiological, pharmacological and clinical principles of clindamycin therapy].
    Modde H
    Schweiz Med Wochenschr; 1971 Nov; 101(45):1632-3. PubMed ID: 4947153
    [No Abstract]   [Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Roxarsone (CAS No. 121-19-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Mar; 345():1-198. PubMed ID: 12724787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of Lincocyn (lincomycin) in the treatment of chronic osteomyelitis].
    Maiat VS; Atanov IuP; Dubrovskii AA
    Khirurgiia (Mosk); 1969 Nov; 45(11):86-91. PubMed ID: 5377883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.